Latest Breaking News On - Oxford martin school - Page 22 : vimarsana.com

Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has shown. It is not clear, however, whether these mutated viruses pose an increased risk to patients or are able to evade the vaccine.

United kingdomUnited statesSouth africaTheo sandersonFondation botnarChristopher ruisMegan craigFrancis crick instituteUniversity of cambridgeOxford martin schoolNational institute for healthResearch councilCancer research united kingdomUnited kingdom cystic fibrosisInternational nucleotide sequence database collaborationGlobal initiative on sharing all influenza data